Report to Health Care Cost Growth Target program and Legislative Assembly; contents of report. No later than December 31 of each year, the Prescription Drug Affordability Board shall report to the Health Care Cost Growth Target program established in ORS 442.386 and to the interim committees of the Legislative Assembly related to health, in the manner provided in ORS 192.245, the following information

(1) Price trends for the list of prescription drugs provided to the board by the Department of Consumer and Business Services under ORS 646A.694 (1);

(2) The prescription drugs that were reviewed under ORS 646A.694 (1);

(3) The status of the generic drug market as described in ORS 646A.697; and

(4) Recommendations, if any, for legislative changes necessary to make prescription drug products more affordable in this state. [2021 c.598 §5; 2025 c.166 §3]